<DOC>
	<DOCNO>NCT02376738</DOCNO>
	<brief_summary>This study aim evaluate role leukocyte activation coronary artery disease</brief_summary>
	<brief_title>Regional Activation Leukocytes Coronary Artery Disease</brief_title>
	<detailed_description>1 . The primary aim REAL CAD determine regional difference leukocyte activation different vascular bed vivo . 2 . The secondary aim investigate difference leukocyte activation diabetic CAD subject patient suffer . 3 . The third aim investigate relationship complement component , triglyceride leukocyte activation marker order gain insight causative process lead activation leukocyte . 4 . The fourth aim get insight MBL genotype serum level CAD and/or diabetic patient 'healthy ' group include study .</detailed_description>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>Subjects schedule undergo coronary catheterization Provide write informed consent Aged &gt; 18 &lt; 75 year BMI &lt; 35 kg/m2 Emotionally intellectually capable decide participation study consequence participation . Subjects able understand patient information CRP &gt; 20 mg/l Unstable angina pectoris CABG PTCA last 6 month Alcohol use &gt; 2 units/day Aberrations kidney , liver thyroid function Use experimental medication within 6 month catheterization The use immunosuppressive drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>